Your browser doesn't support javascript.
loading
Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
Van Hulst, Glenn; Jorssen, Joseph; Jacobs, Nathalie; Henket, Monique; Louis, Renaud; Schleich, Florence; Bureau, Fabrice; Desmet, Christophe J.
Afiliación
  • Van Hulst G; Laboratory of Cellular and Molecular Immunology, GIGA Institute and Faculty of Veterinary Medicine, Liege University, Liege, Belgium.
  • Jorssen J; Equal contributors.
  • Jacobs N; Laboratory of Cellular and Molecular Immunology, GIGA Institute and Faculty of Veterinary Medicine, Liege University, Liege, Belgium.
  • Henket M; Equal contributors.
  • Louis R; Laboratory of Cellular and Molecular Immunology, GIGA Institute and Faculty of Veterinary Medicine, Liege University, Liege, Belgium.
  • Schleich F; Laboratory of Pneumology, GIGA Institute, Faculty of Medicine and University Hospital Center, Liege University, Liege, Belgium.
  • Bureau F; Laboratory of Pneumology, GIGA Institute, Faculty of Medicine and University Hospital Center, Liege University, Liege, Belgium.
  • Desmet CJ; Laboratory of Pneumology, GIGA Institute, Faculty of Medicine and University Hospital Center, Liege University, Liege, Belgium.
Eur Respir J ; 60(1)2022 07.
Article en En | MEDLINE | ID: mdl-35777778

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Eosinófilos Límite: Humans Idioma: En Revista: Eur Respir J Año: 2022 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Eosinófilos Límite: Humans Idioma: En Revista: Eur Respir J Año: 2022 Tipo del documento: Article País de afiliación: Bélgica